Alert: "Trump’s Tariff Shake-Up: Economic Consequences for the U.S. and the World"
Memphasys Limited (ASX: MEM), a leader in reproductive biotechnology, is expanding its RoXsta™ antioxidant assay system for livestock applications. A recent pilot study in heifers demonstrated RoXsta™'s ability to accurately measure antioxidant levels, validating its technical functionality, though no direct link to pregnancy outcomes was found. Importantly, the study highlighted more promising applications in bulls, where oxidative stress more significantly affects semen quality. A new large-scale bull fertility study, backed by a multinational veterinary pharmaceutical partner, is set to commence with 120 bulls. RoXsta™ also showed early potential in detecting mastitis in dairy cattle—a condition affecting 17% of global dairy cows—offering prospects for timely intervention and reduced losses. Memphasys’ commitment to innovation is reflected in ongoing collaborations with leading universities and support from industry partners, positioning RoXsta™ as a scalable and valuable diagnostic tool across animal reproductive health.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Apr 03, 2025
Apr 03, 2025
Apr 03, 2025
Apr 03, 2025
Apr 03, 2025
Apr 03, 2025
Apr 03, 2025
Apr 03, 2025
Apr 02, 2025
Apr 02, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.